Aligned with newly issued FDA Draft Guidance, Phoenix supports electronic data, methods and results audit, traceability and communication requirements PRINCETON, NJ – Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8.2, the industry gold standard in pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation software for drug development. Phoenix is the

To read the full story...

Already a subscriber? Login now

< | >